Cite
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?
MLA
Zachary Rivers, et al. “Can Cost-Effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?” Cancer Epidemiology, Biomarkersprevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 30, no. 6, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f94d1894e2d578888058da8494d8e02f&authtype=sso&custid=ns315887.
APA
Zachary Rivers, Trang H. Au, Cornelia M. Ulrich, David D. Stenehjem, Diana I. Brixner, Brandon S. Walker, Eman Biltaji, Jennifer Ose, & Christopher I. Li. (2020). Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? Cancer Epidemiology, Biomarkersprevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 30(6).
Chicago
Zachary Rivers, Trang H. Au, Cornelia M. Ulrich, David D. Stenehjem, Diana I. Brixner, Brandon S. Walker, Eman Biltaji, Jennifer Ose, and Christopher I. Li. 2020. “Can Cost-Effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?” Cancer Epidemiology, Biomarkersprevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 30 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f94d1894e2d578888058da8494d8e02f&authtype=sso&custid=ns315887.